GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (FRA:MIS) » Definitions » Debt-to-Equity

Monash IVF Group (FRA:MIS) Debt-to-Equity : 0.44 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Monash IVF Group Debt-to-Equity?

Monash IVF Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €30.5 Mil. Monash IVF Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €44.2 Mil. Monash IVF Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €169.7 Mil. Monash IVF Group's debt to equity for the quarter that ended in Dec. 2023 was 0.44.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Monash IVF Group's Debt-to-Equity or its related term are showing as below:

FRA:MIS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.16   Med: 0.56   Max: 0.77
Current: 0.44

During the past 10 years, the highest Debt-to-Equity Ratio of Monash IVF Group was 0.77. The lowest was 0.16. And the median was 0.56.

FRA:MIS's Debt-to-Equity is ranked worse than
63.78% of 196 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs FRA:MIS: 0.44

Monash IVF Group Debt-to-Equity Historical Data

The historical data trend for Monash IVF Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monash IVF Group Debt-to-Equity Chart

Monash IVF Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.23 0.17 0.29 0.37

Monash IVF Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.29 0.32 0.37 0.44

Competitive Comparison of Monash IVF Group's Debt-to-Equity

For the Diagnostics & Research subindustry, Monash IVF Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monash IVF Group's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Monash IVF Group's Debt-to-Equity falls into.



Monash IVF Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Monash IVF Group's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Monash IVF Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monash IVF Group  (FRA:MIS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Monash IVF Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Monash IVF Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Monash IVF Group (FRA:MIS) Business Description

Traded in Other Exchanges
Address
510 Church Street, Level 1, Cremorne, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a specialist assisted reproductive services provider. The company offers specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments. The company's operating segment includes Australia and International. It generates maximum revenue from the Australian segment. Australian segment is a provider of Assisted Reproductive Services, Ultrasound, and other related services. The International segment is a provider of Assisted Reproductive Services in Malaysia.

Monash IVF Group (FRA:MIS) Headlines

No Headlines